A clinical study of the anti-diabetic effect of a simple Chinese herbal formula, PSP-1

被引:1
|
作者
Chui, S. H. [1 ,2 ]
Wong, Y. H. [2 ]
Fong, M. Y. [2 ]
Chow, F. C.
Chiu, Y. M. [2 ,3 ]
Lam, C. W. K. [1 ]
机构
[1] Macau Univ Sci & Technol Fdn, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China
[2] Diagnostix Med Ctr, Cent, Clin Lab, Hong Kong, Hong Kong, Peoples R China
[3] Modern TCM Ltd, Hong Kong, Hong Kong, Peoples R China
关键词
Diabetes; Pre-diabetes; Fasting glucose; HbA1c; Chinese medicine; DIABETES-MELLITUS; NATURAL-PRODUCTS; COMPLICATIONS; MECHANISM;
D O I
10.1016/j.eujim.2016.02.009
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Introduction: A two armed clinical before and after study was conducted to investigate the efficacy of a proprietary Chinese herbal formula, PSP-1, to improve glycemic control in type 2 diabetic patients and pre-diabetic subjects over a 3 month period. Methods: Sixty-two subjects were recruited and divided into a Diabetic Group (DG) and a Pre-diabetic Group (PG). All subjects were prescribed PSP-1 or placebo and followed-up for 3 months. Blood and spot urine samples were collected at baseline, 1st month and 3rd month for each subject for laboratory tests. Results: For the DG group, PSP-1 subjects showed significant decrease in blood HbA1c level between baseline and 3 months post PSP-1 (p < 0.005), but there was no significant change in fasting plasma glucose concentration. PSP-1 subjects in the PG group showed a significant decrease in both fasting glucose (p < 0.05) and HbA1c (p = 0.001) after 3-months' treatment. Combining PG and DG groups, a significant decrease in HbA1c was observed for PSP subjects between baseline and 3 months post PSP. Comparison with those on placebo demonstrated no significant changes in either HbA1c level or glucose concentrations. Conclusions: It appeared that 3 months supplementation of PSP-1 formulation was able to reduce blood glucose concentrations in pre-diabetic subjects and lowered blood HbA1c levels for both pre-diabetic and diabetic subjects. (C) 2016 Elsevier GmbH. All rights reserved.
引用
收藏
页码:458 / 464
页数:7
相关论文
共 50 条
  • [41] Anti-inflammatory Effect of the Chinese Herbal Formula-FAHF-2 on PBMCs from Children with Crohn's Disease
    Song, Y.
    Dunkin, D.
    Ceballos, C.
    Hoffstadter-Thal, K.
    Benkov, K.
    Li, X.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB205 - AB205
  • [42] Liposomal formulations of glucagon-like peptide-1: Improved bioavailability and anti-diabetic effect
    Hanato, Junko
    Kuriyama, Kazuki
    Mizumoto, Takahiro
    Debari, Kazuhiro
    Hatanaka, Junya
    Onoue, Satomi
    Yamada, Shizuo
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 382 (1-2) : 111 - 116
  • [43] Effect of Anti-diabetic Drugs on Cardiovascular Mortality And Heart Failure Hospitalizations: A Meta-analysis Study
    Ganta, Nitheesha
    Gonzalez, Hilda
    Ogunti, Richard
    Opoku-Asare, Isaac
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S56 - S57
  • [44] Jiang Tang Xiao Ke Granule, a Classic Chinese Herbal Formula, Improves the Effect of Metformin on Lipid and Glucose Metabolism in Diabetic Mice
    Zhang, Yi
    An, Hong
    Pan, Si-Yuan
    Zhao, Dan-Dan
    Zuo, Jia-Cheng
    Li, Xiao-Ke
    Gao, Ya
    Mu, Qian-Qian
    Yu, Na
    Ma, Yue
    Mo, Fang-Fang
    Gao, Si-Hua
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [45] POTENTIATION OF ANTI-TUMOR EFFECT OF CYCLOPHOSPHAMIDE AND HYDRAZINE SULFATE BY TREATMENT WITH THE ANTI-DIABETIC AGENT, 1-PHENYLETHYLBIGUANIDE (PHENFORMIN)
    DILMAN, VM
    ANISIMOV, VN
    CANCER LETTERS, 1979, 7 (06) : 357 - 361
  • [46] Efficacy and Safety of a Chinese Herbal Medicine Formula (RCM-104) in the Management of Simple Obesity: A Randomized, Placebo-Controlled Clinical Trial
    Lenon, George Binh
    Li, Kang Xiao
    Chang, Yung-Hsien
    Yang, Angela Weihong
    Da Costa, Clifford
    Li, Chun Guang
    Cohen, Marc
    Mann, Neil
    Xue, Charlie C. L.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [47] Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial
    Zhao, Xue-min
    Zhang, Ying
    He, Xin-hui
    Chen, Hong-dong
    Wang, Zhu-feng
    Guo, Jing
    Wang, Xin-miao
    Gao, Ze-zheng
    Wang, Ji-ping
    Liu, Wei
    Zhao, Lin-hua
    Tong, Xiao-lin
    TRIALS, 2018, 19
  • [48] Preliminary in vitro study of anti-oxidant activity and anti-diabetic potential of plant extracts from 4 herbal substances not traditionally used for treatment of diabetes mellitus
    Trifonova, Dora
    Gavrilova, Anna
    Dyakova, Galina
    Gavrilov, Genadi
    Yotova, Maya
    Nikolov, Stefan
    PHARMACIA, 2021, 68 (04) : 755 - 762
  • [49] Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial
    Xue-min Zhao
    Ying Zhang
    Xin-hui He
    Hong-dong Chen
    Zhu-feng Wang
    Jing Guo
    Xin-miao Wang
    Ze-zheng Gao
    Ji-ping Wang
    Wei Liu
    Lin-hua Zhao
    Xiao-lin Tong
    Trials, 19
  • [50] Effect of ANGIPARS™, a new herbal drug on diabetic foot ulcer:: A phase 2 clinical study
    Masoompour, S. M.
    Bagheri, M. H.
    Borhani, Haghighi A.
    Novitsky, Y. A.
    Sadeghi, B.
    Gharibdoust, F.
    Larijani, B.
    Ranjbar, Omrani G.
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 16 : 31 - 34